Skip to main content

Site notifications

AusPAR: RINVOQ

Australian Public Assessment Report
Device/Product Name
Rinvoq
Active ingredients
Upadacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-04791-1-1
Submission Type
Extension of indications and major variation (new strength)
Decision
Approved

Help us improve the Therapeutic Goods Administration site